Sonnet Biotherapeutics Holdings Inc. (SONN)
Market Open
2 Dec, 21:00
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
1. 26
-1.84
-59.3548%
$
8.43M Market Cap
- P/E Ratio
- Div Yield
10.43M Volume
-1.23 Eps
$ 3.1
Previous Close Want to track SONN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
This stock rockets 260% after $900 million mega crypto deal
Shares of Sonnet BioTherapeutics (NASDAQ: SONN) soared in pre-market trading on Monday after the company announced a $888 million business combination to pivot into the cryptocurrency sector.
Finbold | 1 year ago
Sonnet BioTherapeutics (NASDAQ:SONN) Participates in Virtual Investor "What This Means" Segment Hosted by JTC Team
Watch the "What This Means" segment here FRENCHTOWN, NJ / ACCESSWIRE / July 24, 2024 / JTC Team ("JTC"), a fully integrated corporate communications and investor relations firm, today released a Virtual Investor "What This Means" segment featuring Sonnet BioTherapeutics, Inc. (Nasdaq:SONN), a clinical-stage company developing targeted immunotherapeutic drugs. As part of the "What This Means" segment, Pankaj Mohan, PhD, Founder and Chief Executive Officer, Richard Kenney, M.D.
Accesswire | 2 years ago
